$1.35
0.075.47%
In chiusura: Nov 21, 4:00 PM EST
$1.25
-0.10-7.41%
After hour: Nov 21, 9:29 AM EST
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Ernexa Therapeutics Inc (NASDAQ:ERNA) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 39.60K a 713.39K. Questo rappresenta il 12.01% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 18.15M azioni scambiate al giorno, ci vorrebbero 1 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
713.39K
Vendite allo scoperto %
12.0%
Giorni di copertura
1
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ERNA | Ernexa Therapeutics Inc. Commo | 10/31/2025 | 11/11/2025 | 12.01% | 5,940,083 | 713,392 | 18,145,885 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 10/15/2025 | 10/24/2025 | 0.67% | 5,940,083 | 39,599 | 75,654 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 09/30/2025 | 10/09/2025 | 0.93% | 5,940,083 | 55,470 | 229,439 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 09/15/2025 | 09/24/2025 | 0.63% | 5,940,083 | 37,514 | 125,108 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 08/29/2025 | 09/10/2025 | 0.76% | 5,940,083 | 45,294 | 47,379 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 08/15/2025 | 08/26/2025 | 0.83% | 5,940,083 | 49,468 | 31,470 | 1.57 | |
ERNA | Ernexa Therapeutics Inc. Commo | 07/31/2025 | 08/11/2025 | 1.11% | 5,940,083 | 66,220 | 125,971 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 07/15/2025 | 07/24/2025 | 0.90% | 5,940,083 | 53,164 | 34,993 | 1.52 | |
ERNA | Ernexa Therapeutics Inc. Commo | 06/30/2025 | 07/10/2025 | 1.03% | 5,940,083 | 61,001 | 158,790 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 06/13/2025 | 06/25/2025 | 0.88% | 5,940,083 | 52,183 | 98,498 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 05/30/2025 | 06/10/2025 | 0.23% | 41,046,994 | 93,338 | 386,367 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 05/15/2025 | 05/27/2025 | 0.31% | 41,046,994 | 127,421 | 211,787 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 04/30/2025 | 05/09/2025 | 0.26% | 40,862,176 | 104,315 | 158,769 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 04/15/2025 | 04/25/2025 | 0.42% | 40,862,176 | 169,773 | 198,827 | 1 | |
ERNA | Ernexa Therapeutics Inc. Commo | 03/31/2025 | 04/09/2025 | 0.59% | 35,610,539 | 210,971 | 231,192 | 1 | |
ERNA | Eterna Therapeutics Inc. Commo | 03/14/2025 | 03/25/2025 | 1.04% | 35,610,539 | 369,164 | 156,098 | 2.36 | |
ERNA | Eterna Therapeutics Inc. Commo | 02/28/2025 | 03/11/2025 | 0.70% | 50,087,038 | 348,163 | 399,987 | 1 | |
ERNA | Eterna Therapeutics Inc. Commo | 02/14/2025 | 02/26/2025 | 0.37% | 50,087,038 | 186,616 | 658,656 | 1 | |
ERNA | Eterna Therapeutics Inc. Commo | 01/31/2025 | 02/11/2025 | 0.62% | 50,087,038 | 309,087 | 2,585,406 | 1 | |
ERNA | Eterna Therapeutics Inc. Commo | 01/15/2025 | 01/27/2025 | 10.95% | 50,087,038 | 5,486,953 | 66,350,332 | 1 | |
ERNA | Eterna Therapeutics Inc. Commo | 12/31/2024 | 01/10/2025 | 0.48% | 50,087,038 | 241,019 | 664,992 | 1 | |
ERNA | Eterna Therapeutics Inc. Commo | 12/13/2024 | 12/24/2024 | 1.21% | 50,087,038 | 606,150 | 3,711,011 | 1 | |
ERNA | Eterna Therapeutics Inc. Commo | 11/29/2024 | 12/10/2024 | 0.23% | 50,087,038 | 115,021 | 327,280 | 1 | |
ERNA | Eterna Therapeutics Inc. Commo | 11/15/2024 | 11/26/2024 | 0.09% | 50,087,038 | 47,428 | 119,686 | 1 | |
ERNA | Eterna Therapeutics Inc. Commo | 10/31/2024 | 11/11/2024 | 1.08% | 4,122,913 | 44,458 | 43,382 | 1.02 | |
ERNA | Eterna Therapeutics Inc. Commo | 10/15/2024 | 10/24/2024 | 1.48% | 4,122,913 | 61,003 | 23,263 | 2.62 | |
ERNA | Eterna Therapeutics Inc. Commo | 09/30/2024 | 10/09/2024 | 1.32% | 4,126,026 | 54,421 | 94,758 | 1 | |
ERNA | Eterna Therapeutics Inc. Commo | 09/13/2024 | 09/24/2024 | 0.89% | 4,126,026 | 36,603 | 9,292 | 3.94 | |
ERNA | Eterna Therapeutics Inc. Commo | 08/30/2024 | 09/11/2024 | 0.81% | 4,126,026 | 33,233 | 2,652 | 12.53 | |
ERNA | Eterna Therapeutics Inc. Commo | 08/15/2024 | 08/26/2024 | 0.90% | 4,126,026 | 37,055 | 6,073 | 6.1 | |
ERNA | Eterna Therapeutics Inc. Commo | 07/31/2024 | 08/09/2024 | 0.92% | 4,125,769 | 37,962 | 16,963 | 2.24 | |
ERNA | Eterna Therapeutics Inc. Commo | 07/15/2024 | 07/24/2024 | 1.24% | 4,125,769 | 51,303 | 5,375 | 9.54 | |
ERNA | Eterna Therapeutics Inc. Commo | 06/28/2024 | 07/10/2024 | 1.32% | 4,125,769 | 54,500 | 5,785 | 9.42 | |
ERNA | Eterna Therapeutics Inc. Commo | 06/14/2024 | 06/26/2024 | 1.33% | 4,125,769 | 54,951 | 3,902 | 14.08 | |
ERNA | Eterna Therapeutics Inc. Commo | 05/31/2024 | 06/11/2024 | 1.16% | 4,125,769 | 47,721 | 8,326 | 5.73 | |
ERNA | Eterna Therapeutics Inc. Commo | 05/15/2024 | 05/24/2024 | 1.28% | 4,125,769 | 52,838 | 12,124 | 4.36 | |
ERNA | Eterna Therapeutics Inc. Commo | 04/30/2024 | 05/09/2024 | 0.83% | 4,125,769 | 34,196 | 6,840 | 5 | |
ERNA | Eterna Therapeutics Inc. Commo | 04/15/2024 | 04/24/2024 | 0.97% | 4,125,769 | 40,081 | 3,845 | 10.42 | |
ERNA | Eterna Therapeutics Inc. Commo | 03/28/2024 | 04/09/2024 | 1.03% | 4,125,769 | 42,434 | 6,822 | 6.22 | |
ERNA | Eterna Therapeutics Inc. Commo | 03/15/2024 | 03/26/2024 | 0.82% | 4,125,769 | 33,629 | 19,564 | 1.72 | |
ERNA | Eterna Therapeutics Inc. Commo | 02/29/2024 | 03/11/2024 | 1.05% | 3,600,459 | 37,782 | 4,580 | 8.25 | |
ERNA | Eterna Therapeutics Inc. Commo | 02/15/2024 | 02/27/2024 | 4.08% | 3,600,459 | 146,808 | 8,260 | 17.77 | |
ERNA | Eterna Therapeutics Inc. Commo | 01/31/2024 | 02/09/2024 | 4.11% | 3,600,459 | 147,866 | 9,587 | 15.42 | |
ERNA | Eterna Therapeutics Inc. Commo | 01/12/2024 | 01/24/2024 | 3.68% | 3,600,459 | 132,442 | 10,611 | 12.48 | |
ERNA | Eterna Therapeutics Inc. Commo | 12/29/2023 | 01/10/2024 | 3.72% | 3,600,459 | 134,020 | 29,573 | 4.53 | |
ERNA | Eterna Therapeutics Inc. Commo | 12/15/2023 | 12/27/2023 | 1.03% | 3,600,459 | 37,122 | 109,615 | 1 | |
ERNA | Eterna Therapeutics Inc. Commo | 11/30/2023 | 12/11/2023 | 3.19% | 3,600,459 | 114,732 | 27,393 | 4.19 | |
ERNA | Eterna Therapeutics Inc. Commo | 11/15/2023 | 11/27/2023 | 3.43% | 3,600,459 | 123,330 | 20,095 | 6.14 |
In cerca di azioni più vendute allo scoperto?